These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 17045310)
21. Interactions of imidazoline ligands with the active site of purified monoamine oxidase A. Jones TZ; Giurato L; Guccione S; Ramsay RR FEBS J; 2007 Mar; 274(6):1567-75. PubMed ID: 17480205 [TBL] [Abstract][Full Text] [Related]
22. Down-regulation of MAO-B activity and imidazoline receptors in rat brain following chronic treatment of morphine. Su RB; Li J; Li X; Qin BY Acta Pharmacol Sin; 2001 Jul; 22(7):639-44. PubMed ID: 11749830 [TBL] [Abstract][Full Text] [Related]
23. Imidazoline-binding domains on monoamine oxidase B and subpopulations of enzyme. Raddatz R; Savic SL; Bakthavachalam V; Lesnick J; Jasper JR; McGrath CR; Parini A; Lanier SM J Pharmacol Exp Ther; 2000 Mar; 292(3):1135-45. PubMed ID: 10688633 [TBL] [Abstract][Full Text] [Related]
24. On the formation and nature of the imidazoline I2 binding site on human monoamine oxidase-B. McDonald GR; Olivieri A; Ramsay RR; Holt A Pharmacol Res; 2010 Dec; 62(6):475-88. PubMed ID: 20832472 [TBL] [Abstract][Full Text] [Related]
25. 3H[2-(2-benzofuranyl)-2-imidazoline] (BFI) binding in human platelets: modulation by tranylcypromine. Wiest SA; Steinberg MI Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):209-16. PubMed ID: 10494892 [TBL] [Abstract][Full Text] [Related]
26. Photoaffinity labeling of human placental monoamine oxidase-A by 4-fluoro-3-nitrophenyl azide. Hsu MC; Shih JC Mol Pharmacol; 1988 Feb; 33(2):237-41. PubMed ID: 3340083 [TBL] [Abstract][Full Text] [Related]
27. Binding of [3H]2-(2-benzofuranyl)-2-imidazoline (BFI) to human brain: potentiation by tranylcypromine. Wiest SA; Steinberg MI Life Sci; 1997; 60(9):605-15. PubMed ID: 9048963 [TBL] [Abstract][Full Text] [Related]
28. Behavioral effects of the imidazoline I(2) receptor ligand BU99006 in rats. Qiu Y; Thorn DA; Zhang Y; He X; Li JX Behav Pharmacol; 2014 Apr; 25(2):130-6. PubMed ID: 24518265 [TBL] [Abstract][Full Text] [Related]
29. Modulation of MAO activity by imidazoline and guanidine derivatives. Raasch W; Muhle H; Dominiak P Ann N Y Acad Sci; 1999 Jun; 881():313-31. PubMed ID: 10415932 [TBL] [Abstract][Full Text] [Related]
30. (-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity. Yáñez M; Fraiz N; Cano E; Orallo F Eur J Pharmacol; 2006 Aug; 542(1-3):54-60. PubMed ID: 16828740 [TBL] [Abstract][Full Text] [Related]
31. [Effect of a new antiparkinsonian drug himantane on monoamine oxidase activity]. Val'dman EA; Voronina TA; Aksenova LN; Buneeva OA; Medvedev AE Eksp Klin Farmakol; 2003; 66(5):3-5. PubMed ID: 14650204 [TBL] [Abstract][Full Text] [Related]
32. Lipophilicity plays a major role in modulating the inhibition of monoamine oxidase B by 7-substituted coumarins. Carotti A; Altomare C; Catto M; Gnerre C; Summo L; De Marco A; Rose S; Jenner P; Testa B Chem Biodivers; 2006 Feb; 3(2):134-49. PubMed ID: 17193252 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors. Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910 [TBL] [Abstract][Full Text] [Related]
34. Analysis of the pharmacological and molecular heterogeneity of I(2)-imidazoline-binding proteins using monoamine oxidase-deficient mouse models. Remaury A; Raddatz R; Ordener C; Savic S; Shih JC; Chen K; Seif I; De Maeyer E; Lanier SM; Parini A Mol Pharmacol; 2000 Nov; 58(5):1085-90. PubMed ID: 11040057 [TBL] [Abstract][Full Text] [Related]
35. Characterization of the discriminable stimulus produced by 2-BFI: effects of imidazoline I(2)-site ligands, MAOIs, beta-carbolines, agmatine and ibogaine. MacInnes N; Handley SL Br J Pharmacol; 2002 Mar; 135(5):1227-34. PubMed ID: 11877331 [TBL] [Abstract][Full Text] [Related]
36. Calcium disodium edetate enhances type A monoamine oxidase activity in monkey brain. Egashira T; Sakai K; Sakurai M; Takayama F Biol Trace Elem Res; 2003 Sep; 94(3):203-11. PubMed ID: 12972688 [TBL] [Abstract][Full Text] [Related]
37. Increase of monoamine oxidase-B activity in the brain of scrapie-infected hamsters. Adjou KT; Dilda P; Aumond P; Gueddari S; Deslys JP; Dormont D; Seman M Neurochem Int; 2008 Jun; 52(8):1416-21. PubMed ID: 18442871 [TBL] [Abstract][Full Text] [Related]
38. Binding of the imidazoline ligand 3H-2-benzofuranyl-2-imidazoline (BFI) to human brain and platelets. Potentiation by tranylcypromine and role of MAO isoforms. Steinberg MI; Wiest SA; Pickard RT; Chen K; Shih JC Ann N Y Acad Sci; 1999 Jun; 881():193-8. PubMed ID: 10415915 [No Abstract] [Full Text] [Related]
39. In vivo effects of the I(2)-alkylating agent BU99006 on the immunodensity of imidazoline receptor proteins in the mouse brain. Garcia-Sevilla JA; Ferrer-Alcon M Ann N Y Acad Sci; 2003 Dec; 1009():323-31. PubMed ID: 15028606 [TBL] [Abstract][Full Text] [Related]
40. Calcium alters monoamine oxidase-A parameters in human cerebellar and rat glial C6 cell extracts: possible influence by distinct signalling pathways. Cao X; Li XM; Mousseau DD Life Sci; 2009 Jul; 85(5-6):262-8. PubMed ID: 19539632 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]